Treatment-Free Remission in Chronic Myeloid Leukemia

  Abstract:  Tyrosine kinase inhibitors (TKIs) represent a major breakthrough in the treatment of chronic myeloid leukemia (CML). Thanks to these agents, CML has been transformed […]